We are live on
!
Find out more
CIAS
CFS Investment Advisory Services Portfolio holdings
AUM
$1.5B
1-Year Est. Return
20.41%
This Fund
S&P 500
This Quarter
Est. Return
-4.17%
1 Year Est. Return
+20.41%
3 Year Est. Return
+54.13%
5 Year Est. Return
+54.94%
10 Year Est. Return
–
AUM
$23M
AUM Growth
-$722M
(-97%)
Cap. Flow
+$90.9B
Cap. Flow
% of AUM
395,574.89%
Top 10 Holdings %
Top 10 Hldgs %
51.02%
Holding
568
New
354
Increased
211
Reduced
–
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Growth ETF
VUG
|
+$6.77B |
| 2 |
iShares ESG Aware MSCI USA ETF
ESGU
|
+$6.38B |
| 3 |
Amazon
AMZN
|
+$5.27B |
| 4 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$4.37B |
| 5 |
iShares Russell 1000 Value ETF
IWD
|
+$2.95B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
+$246K |
| 2 |
VanEck Semiconductor ETF
SMH
|
+$220K |
| 3 |
TSMC
TSM
|
+$208K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 4.04% |
| 2 | Financials | 1.2% |
| 3 | Healthcare | 0.77% |
| 4 | Industrials | 0.76% |
| 5 | Technology | 0.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Bio-Rad Laboratories Class A
BIO
$9.53B
| $0 | ﹤0.01% |
+39,989
| New | +$24.1M |
|
|
BNY
427
Bank of New York Mellon
BNY
$109B
| $0 | ﹤0.01% |
+15,584
| New | +$886K |
|
428
Baker Hughes
BKR
$64.3B
| $0 | ﹤0.01% |
+13,617
| New | +$413K |
|
429
Blackrock
BLK
$178B
| $0 | ﹤0.01% |
+113,861
| New | +$89M |
|
430
CACI
CACI
$14.8B
| $0 | ﹤0.01% |
+30,126
| New | +$8.32M |
|
431
Carrier Global
CARR
$52.4B
| $0 | ﹤0.01% |
+20,045
| New | +$944K |
|
432
Cabot Corp
CBT
$4.49B
| $0 | ﹤0.01% |
+10,467
| New | +$690K |
|
433
Crown Castle
CCI
$31.3B
| $0 | ﹤0.01% |
+18,460
| New | +$3.29M |
|
434
Celsius Holdings
CELH
$7.11B
| $0 | ﹤0.01% |
+33,108
| New | +$594K |
|
435
Citizens Financial Group
CFG
$30.7B
| $0 | ﹤0.01% |
+15,276
| New | +$785K |
|
436
Charter Communications
CHTR
$18.8B
| $0 | ﹤0.01% |
+52,915
| New | +$31.1M |
|
437
Cigna
CI
$72.4B
| $0 | ﹤0.01% |
+42,651
| New | +$9.99M |
|
438
Cencora
COR
$63.7B
| $0 | ﹤0.01% |
+30,323
| New | +$4.29M |
|
439
Costco
COST
$419B
| $0 | ﹤0.01% |
+108,836
| New | +$57.1M |
|
440
Salesforce
CRM
$162B
| $0 | ﹤0.01% |
+80,894
| New | +$17.4M |
|
441
CorVel
CRVL
$3.09B
| $0 | ﹤0.01% |
+111,171
| New | +$6.32M |
|
442
Corteva
CTVA
$50.9B
| $0 | ﹤0.01% |
+10,116
| New | +$517K |
|
443
DuPont de Nemours
DD
$19.5B
| $0 | ﹤0.01% |
+20,458
| New | +$2M |
|
|
DFS
444
DELISTED
Discover Financial Services
DFS
| $0 | ﹤0.01% |
+14,986
| New | +$1.76M |
|
445
Dollar General
DG
$26.5B
| $0 | ﹤0.01% |
+46,084
| New | +$9.79M |
|
446
Danaher
DHR
$146B
| $0 | ﹤0.01% |
+118,454
| New | +$29.7M |
|
447
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$48.2B
| $0 | ﹤0.01% |
+72,141
| New | +$25M |
|
448
Dow Inc
DOW
$22.6B
| $0 | ﹤0.01% |
+24,277
| New | +$1.46M |
|
449
iShares MSCI KLD 400 Social ETF
DSI
$5.51B
| $0 | ﹤0.01% |
+15,245
| New | +$1.31M |
|
450
DTE Energy
DTE
$28.6B
| $0 | ﹤0.01% |
+21,021
| New | +$2.56M |
|
Similar funds
NSGL
TP
AAM
SGM
CP
BFO
CPA
MCM
CFS Investment Advisory Services's Q1 2022 Portfolio in Review
As of Q1 2022, CFS Investment Advisory Services held 568 positions worth $23M, down 97% from $745M the previous quarter. Its ten largest holdings account for 51% of the portfolio.
CFS Investment Advisory Services deployed $90.9B of net new capital in Q1 2022, opening 354 new positions and adding to 211 existing holdings. Its largest new stake was Thermo Fisher Scientific: 246,892 shares worth $0.
By sector, the portfolio is most concentrated in Consumer Staples at 4% of assets, up from 4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the most notable exit was Royal Dutch Shell PLC ADS Class A, an estimated $246K sold.
- CFS Investment Advisory Services's largest Q1 2022 buy was Thermo Fisher Scientific: 246,892 shares worth $0.
- CFS Investment Advisory Services added most to Vanguard Morningstar Growth ETF in Q1 2022, an estimated $6.77B increase.
- CFS Investment Advisory Services fully exited Royal Dutch Shell PLC ADS Class A in Q1 2022, selling an estimated $246K.
- CFS Investment Advisory Services's ten largest holdings make up 51% of its $23M portfolio in Q1 2022.
- CFS Investment Advisory Services opened 354 new positions and closed 3 in Q1 2022.
- CFS Investment Advisory Services's portfolio value fell 97% quarter-over-quarter to $23M.
Based on CFS Investment Advisory Services's 13F filing for Q1 2022, filed 27 May 2022.